Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) is a research paper published in Cancers (2020). On theSindex it has a DataRank of 0.510. It has been cited 29 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.510
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01 CA219154
DOD Prostate Cancer Research Program
Grant: X81XWH-19-1-0227
NIGMS NIH HHS
Grant: T32 GM140935
NCI NIH HHS
Grant: T32 CA009135
NIGMS NIH HHS
Grant: T32 GM008692
National Institutes of Health
Grant: 5R01CA219154-04
Effective Anti-Tumor Vaccination - Targeting Checkpoint Regulation at the Time of T-cell Activation
FWCI
1.01
Citation Percentile
0.8%
Influential Citations
2
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals